Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)

Starting soon

Conditions studied: HIV - Human Immunodeficiency Virus

In brief

The risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated atherosclerosis, caused by chronic inflammation and immune dysregulation. The measurement of coronary calcium using plain computed tomography is a subclinical indicator of coronary atherosclerosis and is associated with the risk of cardiovascular events and mortality in the general population.

Key facts

Study ID

NCT07662161

Run by

Instituto Mexicano del Seguro Social

People needed

384

Starts

2026-07-01

Expected to finish

2030-07-01

Last updated by the study team

2026-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have been diagnosed with HIV infection for more than 6 months
• Undetectable viral load

You may not qualify if…

• Patients who have previously taken statins
• Patients with chronic ischemic heart disease that has required stenting or revascularization

Where it is running

• Instituto Mexicano del Seguro Social — León, Guanajuato, Mexico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.